Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
| colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | | colspan="6" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations''' | ||
! colspan=" | ! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings | ||
|- | |- | ||
Line 10: | Line 10: | ||
|- | |- | ||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
|- | |- | ||
Line 22: | Line 21: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab 2 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab 2 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab 3 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab 3 | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous squamous cell carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous squamous cell carcinoma''' | ||
Line 33: | Line 29: | ||
| style="background: #F5F5F5; padding: 5px;" |Hyperkeratotic | | style="background: #F5F5F5; padding: 5px;" |Hyperkeratotic | ||
| style="background: #F5F5F5; padding: 5px;" |Increased size | | style="background: #F5F5F5; padding: 5px;" |Increased size | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 50: | Line 43: | ||
| style="background: #F5F5F5; padding: 5px;" |Single pink, red, or purple shiny bump | | style="background: #F5F5F5; padding: 5px;" |Single pink, red, or purple shiny bump | ||
| style="background: #F5F5F5; padding: 5px;" |Painless | | style="background: #F5F5F5; padding: 5px;" |Painless | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 64: | Line 54: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Lump that has been rapidly growing over the past weeks | | style="background: #F5F5F5; padding: 5px;" |Lump that has been rapidly growing over the past weeks | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 84: | Line 71: | ||
| style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border | | style="background: #F5F5F5; padding: 5px;" |Usually have an asymmetrical shape with an irregular border | ||
| style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders | | style="background: #F5F5F5; padding: 5px;" |Red, nonspecific lesion with slightly elevated borders | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 100: | Line 84: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Coarse scale lesion | | style="background: #F5F5F5; padding: 5px;" |Coarse scale lesion | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 117: | Line 98: | ||
| style="background: #F5F5F5; padding: 5px;" |Scaly patch | | style="background: #F5F5F5; padding: 5px;" |Scaly patch | ||
| style="background: #F5F5F5; padding: 5px;" |Erythematous lesion | | style="background: #F5F5F5; padding: 5px;" |Erythematous lesion | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 134: | Line 112: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Pearly papule with telangiectasias | | style="background: #F5F5F5; padding: 5px;" |Pearly papule with telangiectasias | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 150: | Line 125: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Other sites lungs, liver, brain, skin, or bone. | | style="background: #F5F5F5; padding: 5px;" |Other sites lungs, liver, brain, skin, or bone. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 162: | Line 134: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Benign Skin Lesions''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Benign Skin Lesions''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 182: | Line 151: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Yellow-nodule | | style="background: #F5F5F5; padding: 5px;" |Yellow-nodule | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 195: | Line 161: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Rhabdomyosarcoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Rhabdomyosarcoma''' | ||
| style="background: #F5F5F5; padding: 5px;" |Bulging of the eye or a swollen eyelid | | style="background: #F5F5F5; padding: 5px;" |Bulging of the eye or a swollen eyelid | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 216: | Line 179: | ||
| style="background: #F5F5F5; padding: 5px;" |Erythema | | style="background: #F5F5F5; padding: 5px;" |Erythema | ||
| style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size. | | style="background: #F5F5F5; padding: 5px;" |less pigmentation, and tend to be somewhat smaller in size. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 228: | Line 188: | ||
| style="background: #F5F5F5; padding: 5px;" |Hard lesion | | style="background: #F5F5F5; padding: 5px;" |Hard lesion | ||
| style="background: #F5F5F5; padding: 5px;" |Itchy lumps | | style="background: #F5F5F5; padding: 5px;" |Itchy lumps | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 247: | Line 204: | ||
| style="background: #F5F5F5; padding: 5px;" |Eczema-like rash of the skin | | style="background: #F5F5F5; padding: 5px;" |Eczema-like rash of the skin | ||
| style="background: #F5F5F5; padding: 5px;" |Around the genital regions of males and females. | | style="background: #F5F5F5; padding: 5px;" |Around the genital regions of males and females. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 262: | Line 216: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Waxy, "stuck on," often hyperkeratotic appearance | | style="background: #F5F5F5; padding: 5px;" |Waxy, "stuck on," often hyperkeratotic appearance | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 278: | Line 229: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Verrucous lesion | | style="background: #F5F5F5; padding: 5px;" |Verrucous lesion | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 296: | Line 244: | ||
| style="background: #F5F5F5; padding: 5px;" |Red, dome-shaped | | style="background: #F5F5F5; padding: 5px;" |Red, dome-shaped | ||
| style="background: #F5F5F5; padding: 5px;" |Friable papule with a collarette of scale | | style="background: #F5F5F5; padding: 5px;" |Friable papule with a collarette of scale | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 310: | Line 255: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |multiple, red- to brown-colored, small papules that | | style="background: #F5F5F5; padding: 5px;" |multiple, red- to brown-colored, small papules that | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 329: | Line 271: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Coin shaped spots | | style="background: #F5F5F5; padding: 5px;" |Coin shaped spots | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 345: | Line 284: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Thick, white, silvery, or red patches of skin | | style="background: #F5F5F5; padding: 5px;" |Thick, white, silvery, or red patches of skin | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 362: | Line 298: | ||
| style="background: #F5F5F5; padding: 5px;" |Purulent ulcer | | style="background: #F5F5F5; padding: 5px;" |Purulent ulcer | ||
| style="background: #F5F5F5; padding: 5px;" |Ragged and violaceous border | | style="background: #F5F5F5; padding: 5px;" |Ragged and violaceous border | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 373: | Line 306: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Venous stasis ulcers''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Venous stasis ulcers''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 389: | Line 319: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Traumatic ulcers''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Traumatic ulcers''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 409: | Line 336: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Red scaly patch | | style="background: #F5F5F5; padding: 5px;" |Red scaly patch | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 429: | Line 353: | ||
Yellowish, soft, small papules on the face | Yellowish, soft, small papules on the face | ||
| style="background: #F5F5F5; padding: 5px;" |Usually on the nose, cheeks, and forehead | | style="background: #F5F5F5; padding: 5px;" |Usually on the nose, cheeks, and forehead | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 443: | Line 364: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Red rash | | style="background: #F5F5F5; padding: 5px;" |Red rash | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 459: | Line 377: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Red rash | | style="background: #F5F5F5; padding: 5px;" |Red rash | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 475: | Line 390: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Erythematous, dome-shaped papule | | style="background: #F5F5F5; padding: 5px;" |Erythematous, dome-shaped papule | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 487: | Line 399: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nevus''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Nevus''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 503: | Line 412: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Chemical Burns''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Chemical Burns''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 519: | Line 425: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Limbal Dermoid''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Limbal Dermoid''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 536: | Line 439: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Benign hereditary intraepithelial dyskeratosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Benign hereditary intraepithelial dyskeratosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 552: | Line 452: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''primary acquired melanosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''primary acquired melanosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 568: | Line 465: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Fibrous xanthoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Fibrous xanthoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 590: | Line 484: | ||
| style="background: #F5F5F5; padding: 5px;" |Inflamed and hyperpigmented | | style="background: #F5F5F5; padding: 5px;" |Inflamed and hyperpigmented | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |On dermatoscopic evaluation, presence of horned cysts and hairpin-shaped blood vessels | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 606: | Line 497: | ||
| style="background: #F5F5F5; padding: 5px;" |Reddened, yellowish-tan color of lesions | | style="background: #F5F5F5; padding: 5px;" |Reddened, yellowish-tan color of lesions | ||
| style="background: #F5F5F5; padding: 5px;" |Slightly raised bumps | | style="background: #F5F5F5; padding: 5px;" |Slightly raised bumps | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 617: | Line 505: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous fungal infections''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous fungal infections''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 633: | Line 518: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Desmoplastic trichoepithelioma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Desmoplastic trichoepithelioma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 649: | Line 531: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Adnexal carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Adnexal carcinoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 665: | Line 544: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Keratoacanthoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Keratoacanthoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 681: | Line 557: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Darier disease''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Darier disease''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 697: | Line 570: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous T-cell lymphoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous T-cell lymphoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 720: | Line 590: | ||
| style="background: #F5F5F5; padding: 5px;" |Rolled or everted wound margins | | style="background: #F5F5F5; padding: 5px;" |Rolled or everted wound margins | ||
| style="background: #F5F5F5; padding: 5px;" |Bleeding on touch | | style="background: #F5F5F5; padding: 5px;" |Bleeding on touch | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 738: | Line 605: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Increased size | | style="background: #F5F5F5; padding: 5px;" |Increased size | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 747: | Line 611: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Anogenital''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Anogenital''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 770: | Line 631: | ||
| style="background: #F5F5F5; padding: 5px;" |Dome-shaped or crateriform nodules with a central keratotic core | | style="background: #F5F5F5; padding: 5px;" |Dome-shaped or crateriform nodules with a central keratotic core | ||
| style="background: #F5F5F5; padding: 5px;" |Increased size | | style="background: #F5F5F5; padding: 5px;" |Increased size | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 17:32, 14 February 2019
Diseases | Clinical manifestations | Para-clinical findings | Additional findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||
Lab Findings | Histopathology | ||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | |||
Cutaneous squamous cell carcinoma | Pain | Erythema | Indurated | Hyperkeratotic | Increased size |
| |||||
Merkel cell carcinoma | Starts on areas of skin exposed to the sun | Single pink, red, or purple shiny bump | Painless | Blue-red, dome-shaped nodule | |||||||
Nodular malignant melanoma | Lump that has been rapidly growing over the past weeks | Cells proliferate downwards through the skin (vertical growth) |
| ||||||||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | Red, nonspecific lesion with slightly elevated borders |
| |||||||
Basal cell carcinoma | Coarse scale lesion | ||||||||||
Superficial basal cell carcinoma | Scaly patch | Erythematous lesion |
|
||||||||
Nodular basal cell carcinoma | Pearly papule with telangiectasias | ||||||||||
Cutaneous metastases of internal malignancy | Other sites lungs, liver, brain, skin, or bone. | The most frequent site of metastasis for cutaneous SCC is the regional lymph nodes; | |||||||||
Benign Skin Lesions | |||||||||||
Sebaceous cell carcinoma | Yellow-nodule | Suspected due to evidence of eyelash loss | |||||||||
Rhabdomyosarcoma | Bulging of the eye or a swollen eyelid | Develops in skeletal muscles usually | |||||||||
Actinic keratoses | Pain | Hyperkeratosis | Erythema | less pigmentation, and tend to be somewhat smaller in size. | |||||||
Prurigo nodules | Hard lesion | Itchy lumps | |||||||||
Paget disease | Eczema-like rash of the skin | Around the genital regions of males and females. | Similar to mammary paget disease | chronic | |||||||
Inflamed seborrheic keratosis | Waxy, "stuck on," often hyperkeratotic appearance | ||||||||||
Viral warts | Verrucous lesion | Caused by HPV | |||||||||
Pyogenic granuloma | Rapidly growing | Red, dome-shaped | Friable papule with a collarette of scale | ||||||||
Bowenoid papulosis | multiple, red- to brown-colored, small papules that |
| |||||||||
Nummular eczema | Itchy lesions | Coin shaped spots | Chronic condition | ||||||||
Psoriasis | Flaking, inflammation | Thick, white, silvery, or red patches of skin | Chronic condition | ||||||||
Pyoderma gangrenosum | Purulent ulcer | Ragged and violaceous border | |||||||||
Venous stasis ulcers | |||||||||||
Traumatic ulcers | |||||||||||
Bowen Disease | Red scaly patch | Very early form of skin cancer that is very treatable
referred to as squamous cell carcinoma insitu | |||||||||
Sebaceous Hyperplasia | Lesions can be single or multiple lesions |
Yellowish, soft, small papules on the face |
Usually on the nose, cheeks, and forehead | ||||||||
Allergic Contact Dermatitis | Itchy rash | Red rash | Not contagious | ||||||||
Atopic Dermatitis | Itchy rash | Fever | Red rash | Chronic and sometimes accompanied by asthma | |||||||
Atypical Fibroxanthoma | Erythematous, dome-shaped papule | ||||||||||
Nevus | |||||||||||
Chemical Burns | |||||||||||
Limbal Dermoid | Contains choristomatous tissue | Benign congenital tumor | |||||||||
Benign hereditary intraepithelial dyskeratosis | Rare autosomal-dominant disorder of the conjunctiva and oral mucosa | ||||||||||
primary acquired melanosis | |||||||||||
Fibrous xanthoma | Containing fibromatous elements | Arises due to disturbed systemic lipid metabolism | |||||||||
Inflamed seborrheic keratosis | Inflamed and hyperpigmented | On dermatoscopic evaluation, presence of horned cysts and hairpin-shaped blood vessels | |||||||||
Juvenile xanthogranuloma | Reddened, yellowish-tan color of lesions | Slightly raised bumps | Typically | ||||||||
Cutaneous fungal infections | |||||||||||
Desmoplastic trichoepithelioma | |||||||||||
Adnexal carcinoma | Very rare | ||||||||||
Keratoacanthoma | |||||||||||
Darier disease | Keratosis follicularis | ||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides | ||||||||||
Marjolin's ulcer | Lesions in sites of chronic wounds and scars | Excessive granulation tissue, | Rolled or everted wound margins | Bleeding on touch |
| ||||||
Epithelioma cuniculatum | Increased size | Verrucous carcinoma on the plantar foot | |||||||||
Anogenital | also known as giant condyloma acuminatum of Buschke-Loewenstein | ||||||||||
Keratoacanthoma | Found on actinically damaged skin | Rapid initial growth | Dome-shaped or crateriform nodules with a central keratotic core | Increased size | keratocytic epithelial tumors |